Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/23/2008CA2683444A1 Administration of carboline derivatives useful in the treatment of cancer and other diseases
10/23/2008CA2683436A1 Melatonin tablet and methods of preparation and use
10/23/2008CA2683314A1 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer
10/23/2008CA2683098A1 Process for making galantamine
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2683065A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2682929A1 Pharmaceutical compositions comprising irbesartan
10/23/2008CA2682855A1 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
10/23/2008CA2682817A1 Pyrimidinyl-piperazines useful as d3/d2 receptor ligands
10/23/2008CA2682733A1 Axl kinase inhibitors
10/23/2008CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008CA2682598A1 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2682391A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008CA2682378A1 Suspension for visualization of transparent tissue in eye
10/23/2008CA2681787A1 Heterocyclic compounds and their methods of use
10/23/2008CA2681596A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008CA2681444A1 Ranolazine for enhancing insulin secretion
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008CA2680751A1 Anti-fatigue agent
10/23/2008CA2679929A1 Method for producing finely pulverized organic compound particle
10/23/2008CA2679071A1 Oxazolidinone antibiotics
10/23/2008CA2679069A1 Oxazolidinone antibiotic derivatives
10/23/2008CA2678833A1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
10/23/2008CA2678433A1 Pyrano-pyrazole-amines
10/23/2008CA2678134A1 Spiro-pyrano-pyrazole derivatives
10/23/2008CA2668305A1 Azaindole derivatives as cftr modulators
10/23/2008CA2668211A1 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
10/23/2008CA2660201A1 Organic compounds
10/23/2008CA2648864A1 Gene defects and mutant alk kinase in human solid tumors
10/22/2008EP1983054A1 Carbonic anhydrase and methods using the same
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982987A1 Spiro-pyrano-pyrazole derivatives
10/22/2008EP1982986A1 Pyrrolopyridazinone compound
10/22/2008EP1982984A2 Tricyclic thrombin receptor antagonists
10/22/2008EP1982982A1 Novel coumarin derivative having antitumor activity
10/22/2008EP1982981A1 Process for production of lasofoxifene or analogue thereof
10/22/2008EP1982970A1 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
10/22/2008EP1982730A1 Pharmaceutical composition comprising l-carnitine and an antagonist of the membrane adenosine receptors, derivatives and/or pharmaceutically acceptable salts thereof, and their use in the preparation of drugs with non-toxic effect to inhibit the proliferation of neoplastic cells
10/22/2008EP1982724A1 Therapeutic agent for metabolic syndrome and food containing the therapeutic agent
10/22/2008EP1982722A1 Use of oligotide for the treatment of renal diseases
10/22/2008EP1982721A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
10/22/2008EP1982720A1 Ribaviren for use to treat cancer
10/22/2008EP1982719A1 Treatment of hypertension in women receiving hormone replacement therapy
10/22/2008EP1982718A1 Anti-cancer pharmaceutical composition
10/22/2008EP1982717A1 Use of fungicides for treating fish mycoses
10/22/2008EP1982716A1 Novel histidine derivative
10/22/2008EP1982715A1 Use of fungicides for treating fish mycoses
10/22/2008EP1982714A1 Pyrano-pyrazole-amines
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1982712A1 Pharmaceutical formulations in the form of solids, semisolids, in suspension, in solution, in emulsion or in syrup, containing clindamycin and one or more members of the azole family
10/22/2008EP1982711A1 Compositions comprsing nebivolol
10/22/2008EP1982710A1 Composition for prevention of recurrence of stroke
10/22/2008EP1982709A1 Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
10/22/2008EP1982708A1 Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease
10/22/2008EP1982707A1 Use of hydroxytyrosol as anti-aging agent
10/22/2008EP1982706A1 Use of hydroxytyrosol for the treatment of cartilage injury
10/22/2008EP1982705A1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1982702A1 Sirolimus formulation
10/22/2008EP1982701A2 Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
10/22/2008EP1982699A1 A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation
10/22/2008EP1982696A1 Gel for treating wounds
10/22/2008EP1982603A1 Novel use of hydroxytyrosol and olive extracts/concentrates containing it
10/22/2008EP1982559A2 Composition and method of treating hearing loss
10/22/2008EP1982192A1 METHOD FOR ProNGF ASSAY FOR IN VITRO DIAGNOSIS OF CANCER IN PARTICULAR BREAST , THYROID AND LUNG CANCER AND THERAPEUTIC USE OF ProNGF
10/22/2008EP1981987A2 Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
10/22/2008EP1981911A2 Synergistic compositions for treating hiv
10/22/2008EP1981894A2 Tripodal ligands with the coordinating motifs k2-bh2 or k3-bh3 relevant for biomedical applications of organometallic complexes
10/22/2008EP1981892A1 Thieno-pyridine derivatives as mek inhibitors
10/22/2008EP1981890A2 UNSATURATED mTOR INHIBITORS
10/22/2008EP1981888A2 Inhibitors of tyrosine kinases and uses thereof
10/22/2008EP1981887A2 Pyrrolo[2,3,b]pyridine derivatives useful as raf kinase inhibitors
10/22/2008EP1981886A1 7h-pyridoý3,4-d¨pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
10/22/2008EP1981885A2 A method of preparing a 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor
10/22/2008EP1981883A1 Novel heteroaryl substituted benzothiazoles
10/22/2008EP1981882A1 Amide substituted quinolines
10/22/2008EP1981881A1 Tetrahydropyrane antibiotics
10/22/2008EP1981880A2 Use of 4-imidazole derivatives for cns disorders
10/22/2008EP1981879A1 Amino indazole derivatives
10/22/2008EP1981878A1 Indazole heteroaryl derivatives
10/22/2008EP1981877A1 N-hydroxyacrylamide compounds
10/22/2008EP1981876A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
10/22/2008EP1981875A1 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
10/22/2008EP1981874A1 Aminophenyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
10/22/2008EP1981872A1 Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[ (r)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl ester and its use for the treatment of pulmonary disorders
10/22/2008EP1981871A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
10/22/2008EP1981870A2 Compounds and compositions as protein kinase inhibitors
10/22/2008EP1981869A1 New citrate salt of an indole derivative and its pharmaceutical use
10/22/2008EP1981865A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia
10/22/2008EP1981864A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
10/22/2008EP1981858A2 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
10/22/2008EP1981855A2 Substituted bis-amide metalloprotease inhibitors
10/22/2008EP1981852A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
10/22/2008EP1981851A1 Kinase inhibitors and methods of use thereof
10/22/2008EP1981850A2 Demethylpenclomedine analogs and their use as anticancer agents
10/22/2008EP1981849A1 Heterocyclic compounds
10/22/2008EP1981848A2 11-beta hsd1 inhibitors
10/22/2008EP1981847A1 Secondary amines as renin inhibitors
1 ... 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 ... 7860